Clinical Trial Update: Lenalidomide and Dexamethasone in Primary Plasma Cell Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating lenalidomide and dexamethasone in primary plasma cell leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasma Cell Leukemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: IRCCS Centro di Riferimento Oncologico della Basilicata | Conditions: Primary Plasma Cell Leukemia | Phase 2 | Status: COMPLETED